ArticleEuropean journal of pharmacology2008

The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens.

Shafiqur Rahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.